Azelastine Hydrochloride
Who holds supplier records for Azelastine Hydrochloride? 11 organisations hold a current record for Azelastine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), Germany (1), Italy (1), Hungary (1) and 1 other country (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Azelastine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/azelastine-hydrochloride
Reading the evidence
- 11 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 8 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (11)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Azelastine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CORAL DRUGS PVT LTDIndiaCEP Company GMP cert on recordActive DMF 36205 · latest filing Oct 2021
- EVONIK OPERATIONS GMBHGermanyCEP Company GMP cert on recordActive DMF 15440 · latest filing May 2001
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 25356 · latest filing Oct 2011
- URQUIMA SACEP Company GMP cert on recordActive DMF 20314 · latest filing Feb 2007
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 22919 · latest filing Jul 2009
- CURIA ITALY SRLItaly Company GMP cert on recordActive DMF 19422 · latest filing May 2006
- Gedeon RichterHungary Company GMP cert on recordActive DMF 15361 · latest filing Mar 2001
- HORSTER LIFE SCIENCE PVT LTDIndiaActive DMF 44462 · latest filing Jul 2026
- KOREA UNITED PHARMACEUTICALS INCActive DMF 24317 · latest filing Sept 2010
- ZHEJIANG LEPU PHARMACEUTICAL CO., LTD.ChinaActive DMF 36748 · latest filing Mar 2022
- ESTEVE QUIMICA SACEP Company GMP cert on recordInactive DMF 22427 · latest filing Jan 2009
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Azelastine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | CEP 2019-018 - Rev 03 Azelastine hydrochloride | Aug 2025 | — |
| MSN LABORATORIES PRIVATE LIMITED Rudraram Village | IN | CEP 2011-363 - Rev 02 Azelastine hydrochloride | Feb 2025 | — |
| EVONIK OPERATIONS GMBH Essen | DE | CEP 2009-333 - Rev 05 Azelastine hydrochloride | Apr 2024 | — |
| CORAL DRUGS PRIVATE LIMITED New Delhi | IN | R0-CEP 2021-124 - Rev 00 Azelastine hydrochloride | Aug 2022 | — |
| URQUIMA S.A. Palau-solità i Plegamans | ES | R1-CEP 2007-097 - Rev 02 Azelastine hydrochloride | Jun 2021 | — |
| ESTEVE QUIMICA S.A. Barcelona | ES | R1-CEP 2010-010 - Rev 03 Azelastine hydrochloride | Aug 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Azelastine Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- China · Inactive DMF 25626 · filed Dec 2011
- India · Inactive DMF 20186 · filed Jun 2008
- VIATRIS GMBH AND CO KGInactive DMF 8368 · filed Dec 1989
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Azelastine Hydrochloride is an antihistamine used to treat allergic rhinitis and conjunctivitis. It acts by blocking histamine H1 receptors, reducing allergic symptoms.
Chemical identity
- IUPAC name
- 4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;hydrochloride
- Canonical SMILES
- CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl
- InChIKey
- YEJAJYAHJQIWNU-UHFFFAOYSA-N
- Synonyms
- Astelin API, a-5610, astelin, astepro, astepro allergy, azelastine hcl, e-0659, optivar, w-2979m
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Histamine-1 Receptor Antagonist
- Mechanism of action
- Histamine H1 Receptor Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Azelastine Hydrochloride?
11 organisations hold an active US FDA Type II Drug Master File or a CEP for Azelastine Hydrochloride: CORAL DRUGS PVT LTD (India), EVONIK OPERATIONS GMBH (Germany), MSN Laboratories Private Limited (India), URQUIMA SA, Zydus Lifesciences Limited (India), CURIA ITALY SRL (Italy), Gedeon Richter (Hungary) and HORSTER LIFE SCIENCE PVT LTD (India), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Azelastine Hydrochloride Drug Master Files are active?
CORAL DRUGS PVT LTD (DMF 36205), EVONIK OPERATIONS GMBH (DMF 15440), MSN Laboratories Private Limited (DMF 25356), URQUIMA SA (DMF 20314), Zydus Lifesciences Limited (DMF 22919), CURIA ITALY SRL (DMF 19422), Gedeon Richter (DMF 15361) and HORSTER LIFE SCIENCE PVT LTD (DMF 44462) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Azelastine Hydrochloride records mean?
3 organisations have only inactive Type II DMFs for Azelastine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Azelastine Hydrochloride have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Azelastine Hydrochloride on the EDQM register, including ZYDUS LIFESCIENCES LIMITED Vadodara (IN), MSN LABORATORIES PRIVATE LIMITED Rudraram Village (IN), EVONIK OPERATIONS GMBH Essen (DE), CORAL DRUGS PRIVATE LIMITED New Delhi (IN), URQUIMA S.A. Palau-solità i Plegamans (ES) and ESTEVE QUIMICA S.A. Barcelona (ES). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Azelastine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Azelastine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.